Researchers identify two risk factors that indicate higher risk of aggressive prostate cancer

FHS
July 11, 2024
12:31 pm

A recent European Urology Oncology study assessed the mortality risks, based on the Gleason score and clinical parameters, in patients with prostate cancer.

Genentech, Blueprint tout full approval for Gavreto in rare type of lung cancer

Genentech and Blueprint Medicines scored a full FDA approval on Wednesday for Gavreto’s use in a small subset of non-small cell lung cancer patients, nearly

August 10, 2023

Stronger at 60 vs 50 Years Old: Chris Cornell’s Health Journey – BioHackers Lab

On this episode of Biohackers Lab I talk to Chris Cornell. We discuss Chris’s incredible journey of transformation. Despite being in poor shape at 51,

January 30, 2025

AWS Invests $10M to Fight Childhood Diseases with GenAI & Cloud Innovation

Lila, alongside her mom Nicole in 2022 What You Should Know: – Amazon Web Services (AWS) announced a significant $10M commitment to propel research for

June 27, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.